Ustekinumab-Aekn on Blue Shield Rx Enhanced (S2468-004)
Covered, with prior authorization required.
Tier 4 (non-preferred drug). Quantity limit of 0.5 per 28 days.
$714.75
Patient pays / month
$2,144.25
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
USTEKINUMAB-AEKN 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,931.76 for a month. Other covered strengths are listed below.
Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| USTEKINUMAB-AEKN 45 mg/.5mL Injection, Solution | 4 | $714.75 | PA · 0.5 per 28 days |
| USTEKINUMAB-AEKN 90 mg/mL Injection, Solution | 5 | $1,180.53 | PA · 1 per 28 days |
Verify with the plan before prescribing or filling. Member services: (888)239-6469. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s2468-004